Global Health Technologies Coalition Global Health Technologies Coalition
  • Why R&D
  • R&D Facts
  • In Your State
  • Solutions
  • Breakthroughs Blog
  • News & Events
  • Resources
  • About Us
Stay Informed

Global health R&D delivers forNorth Dakota

Map
North Dakota
Select a new state
Select a State
Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois
Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana
Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island
South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming

US government investment in global health R&D has delivered

$647 thousand
to North Dakota research institutions
North Dakota

Neglected diseases in North Dakota

Chikungunya cases
Chikungunya cases
3
Dengue cases
Dengue cases
6
HIV diagnoses
HIV diagnoses
168
Malaria cases
Malaria cases
18
Tuberculosis cases
Tuberculosis cases
105
West Nile cases
West Nile cases
396
Zika cases
Zika cases
3
North Dakota's top USG-funded global health R&D institutions

North Dakota's top USG-funded global health R&D institutions

University of North Dakota
$394 thousand
North Dakota State University
$253 thousand
North Dakota industry in global health R&D

North Dakota industry in global health R&D

Aldevron
Location(s): Fargo

North Dakota's top areas of global health R&D by USG funding

39.1%
Diarrheal diseases
22.3%
Neglected tropical diseases
Helminths
38.6%
Other
Non-allocable
Global health R&D at work in North Dakota
Global health R&D at work in North Dakota

Researchers at the University of North Dakota are studying whether the presence of a parasite in a person’s blood enhances the transmission of Zika. Nematodes are parasitic roundworms that are common in Latin America and the Caribbean, and there is some indication that nematodes may enhance viral transmission. If they have this effect, the discovery could lead to new approaches to combat the Zika virus. Zika, which is spread by mosquitoes, can be transferred from a pregnant woman to her unborn child, causing devastating birth defects. There is no vaccine to prevent infection with Zika nor medicine to cure it. With global travel, this public health threat is not isolated to one part of the world. Addressing Zika and finding a cure is about protecting women, families, and communities everywhere.

Map
Select a new state
Footnotes
  • Methodology
  • USG global health R&D investment to state research institutions/Top USG-funded global health R&D institutions: Authors' analysis of USG investment data from the G-FINDER survey, including funding for R&D for neglected diseases from 2007–2015 and for Ebola and select viral hemorrhagic fevers from 2014–2015. Reflects USG funding received by entities in state including academic and research institutions, product development partnerships, other nonprofits, select corporations, and government research institutions, as well as self-funding or other federal agency transfers received by federal agencies located in state; but excludes pharmaceutical industry data which is aggregated and anonymized in the survey for confidentiality purposes. See methodology for additional details.
  • Case study photo: Pan American Health Organization
Close
advancing innovation to save lives

© 2009–2021, PATH, as secretariat of the Global Health Technologies Coalition.

  • Stay Informed
  • Join Us
  • Contact Us
  • GHTC Member Log In